Huang, S.-F.; Chong, S.-W.; Huang, C.-W.; Hsu, H.-Y.; Pan, K.-T.; Hung, C.-F.; Wu, T.-H.; Lee, C.-W.; Hsieh, C.-H.; Wang, C.-T.;
et al. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines 2022, 10, 2277.
https://doi.org/10.3390/biomedicines10092277
AMA Style
Huang S-F, Chong S-W, Huang C-W, Hsu H-Y, Pan K-T, Hung C-F, Wu T-H, Lee C-W, Hsieh C-H, Wang C-T,
et al. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines. 2022; 10(9):2277.
https://doi.org/10.3390/biomedicines10092277
Chicago/Turabian Style
Huang, Song-Fong, Sio-Wai Chong, Chun-Wei Huang, Heng-Yuan Hsu, Kuang-Tse Pan, Chien-Fu Hung, Tsung-Han Wu, Chao-Wei Lee, Chia-Hsun Hsieh, Ching-Ting Wang,
and et al. 2022. "Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma" Biomedicines 10, no. 9: 2277.
https://doi.org/10.3390/biomedicines10092277
APA Style
Huang, S. -F., Chong, S. -W., Huang, C. -W., Hsu, H. -Y., Pan, K. -T., Hung, C. -F., Wu, T. -H., Lee, C. -W., Hsieh, C. -H., Wang, C. -T., Chai, P. -M., & Yu, M. -C.
(2022). Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines, 10(9), 2277.
https://doi.org/10.3390/biomedicines10092277
